MTSR (Metsera Therapeutics) Earnings growth in current year

MTSR (Metsera Therapeutics) - company brandmark

Metsera Inc (MTSR) relies on external biotechnological laboratories for drug production while maintaining strict quality control. This approach is combined with the eco-friendly design of storage systems and the minimization of chemicals. Drug accessibility is ensured through the outsourcing of distribution and testing. The annual earnings per share growth metric confirms the trend, with the figure recorded at 85.40, illustrating the current efficiency of the business.

MTSR: Metsera Inc Earnings per share growth in current year 02/01/2025 - 11/29/2025

Financial and market metric breakdowns for Metsera Inc (MTSR)

- share price and expert price forecast:
Price Metsera, Inc.|MTSR - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Metsera Therapeutics|MTSR - Enterprise Value
- book capitalization data:
Net Assets per Single Share Metsera|MTSR - Company Book Value|Market-to-Book Ratio metsera.com|MTSR - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Metsera Inc|MTSR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient metsera.com|MTSR - Company Debts|Debts to Net Assets Metsera Therapeutics|MTSR - Company Long-Term Debt|Company Current Liabilities Metsera|Quick Liquidity Indicator metsera.com
- earnings and valuation multiples information:
MTSR - Net Profit|Expected Net Profit Metsera Inc|MTSR - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Metsera Therapeutics|MTSR - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Metsera Therapeutics|MTSR - Operating profit EBITDA|Net earnings per one share for the last twelve months Metsera|MTSR - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months metsera.com|MTSR - Earnings growth in current year|Earnings growth forecast for next year Metsera Inc
Basic company analysis:MTSR - Metsera, Inc.
Finished products of Metsera

Metsera Inc (MTSR) focuses on the organic development of weight-loss drugs through clinical trials without resorting to mergers. By analyzing the relative EPS YoY trend, an investor assesses the earnings per share dynamics, which reflects the efficiency of converting revenue into net income and the business's ability to generate value, while eliminating the risk of capital freeze during a sharp cooling of market demand.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Pharma) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics Corp|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (akerotx.com)|Earnings per share growth in current year MoonLake MLTX|Crinetics Pharmaceuticals, Inc. (CRNX) - Earnings per share growth rate in current year|NAMS - Earnings per share growth in current year|SLNO: Earnings per share growth in current year|FOLD: Earnings growth in current year|ETNB - Expected net earnings per share growth this year|Earnings per share growth in current year Agios Pharmaceuticals, Inc.|Structure Therapeutics Inc (GPCR) - Expected net earnings per share growth this year|Earnings per share growth in current year MiMedx Group (MDXG)|Net earnings per share growth this year Rezolute Bio RZLT|Earnings per share growth in current year Lexicon Pharmaceuticals LXRX|MBX - Net earnings per share growth this year|Altimmune - Earnings growth in current year|Earnings per share growth rate in current year Aardvark Therapeutics Inc.|SGMT (Sagimet) - Net earnings per share growth this year|BIOA: Net earnings per one share growth for the current year|Earnings per share growth in current year Biomea Fusion, Inc.|Quince (QNCX) - Expected net earnings per share growth this year|Earnings growth in current year GUTS|VTVT - Earnings per share growth rate in current year|Earnings per share growth in current year Agape ATP ATPC|Earnings per share increase in current year PLUR|Synlogic Corp - Earnings growth in current year|LPCN - Earnings growth in current year|MTNB (matinasbiopharma.com) - Net earnings per share growth this year|sprucebiosciences.com - Earnings per share increase in current year|GLTO (Galecto Corp) - Earnings growth in current year|Carmell Therapeutics (CTCX) - Expected net earnings per share growth this year|Earnings per share growth in current year Lumos Pharma, Inc. (LUMO)|organovo.com - Earnings per share growth this year|Earnings growth in current year RDUS (Radius Recycling)